WG
PRAH

Winton Group’s PRA Health Sciences, Inc. PRAH Stock Holding History

Winton Group’s Portfolio PRAH Stock Details PRAH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-4,951
Closed -$759K – 1554
2021
Q1 		$759K Sell
4,951
-890
-15% -$121K 0.04% 627
2020
Q4 		$733K Sell
5,841
-10,515
-64% -$1.18M 0.05% 581
2020
Q3 		$1.66M Buy
16,356
+6,792
+71% +$692K 0.05% 619
2020
Q2 		$930K Buy
9,564
+3,701
+63% +$344K 0.02% 992
2020
Q1 		$487K Buy
+5,863
New +$572K 0.01% 1039
2019
Q4 		– Sell
-21,348
Closed -$2.12M – 1847
2019
Q3 		$2.12M Buy
21,348
+14,302
+203% +$1.42M 0.03% 549
2019
Q2 		$699K Buy
7,046
+1,852
+36% +$177K 0.01% 537
2019
Q1 		$573K Buy
5,194
+1,625
+46% +$170K 0.01% 524
2018
Q4 		$328K Sell
3,569
-2,302
-39% -$233K 0.01% 630
2018
Q3 		$647K Buy
5,871
+33
+0.6% +$3.44K 0.01% 530
2018
Q2 		$545K Sell
5,838
-9,654
-62% -$831K 0.01% 617
2018
Q1 		$1.28M Buy
+15,492
New +$1.38M 0.04% 422

Other funds holding PRAH

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
UOC
UBS O'Connor Chicago, Illinois $3.38B AUM 63.08% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
GCL
Glazer Capital LLC New York $4.71B AUM 81.93% 1-Year Est. Return

Winton Group's PRAH Position: Q2 2021 in Review

Winton Group sold out of PRA Health Sciences, Inc. (PRAH) in Q2 2021, closing a stake of 4,951 shares — an estimated $759K sold.

Winton Group first reported a position in PRAH in Q1 2018 and held it in 12 quarters. The position peaked at $2.12M in Q3 2019. 317 funds tracked by Wall St. Rank hold PRAH as of Q2 2021.

  • Winton Group reported no remaining PRA Health Sciences, Inc. position as of Q2 2021 after selling out during the quarter.
  • Winton Group sold 4,951 PRA Health Sciences, Inc. shares in Q2 2021, an estimated $759K.
  • Winton Group first reported a position in PRA Health Sciences, Inc. in Q1 2018 and held it in 12 quarters.
  • Winton Group's PRA Health Sciences, Inc. position peaked at $2.12M in Q3 2019.
  • 317 funds tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q2 2021.

Based on Winton Group's 13F filing for Q2 2021, filed 10 Aug 2021.